ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
Bioorganic & Medicinal Chemistry
Volume 15, Issue 18, 15 September 2007, Pages 6236-6241
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (160 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bmc.2007.06.022    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2007 Elsevier Ltd All rights reserved.

Molecular design of anti-MRSA agents based on the anacardic acid scaffold

Ivan R. Greena, Corresponding Author Contact Information, E-mail The Corresponding Author, Felismino E. Tocolia, Sang Hwa Leeb, Ken-ichi Niheib and Isao Kubob, Corresponding Author Contact Information, E-mail The Corresponding Author

aDepartment of Chemistry, University of the Western Cape, Bellville 7530, South Africa bDepartment of Environmental Science, Policy and Management, University of California, Berkeley, CA 94720-3112, USA

Received 21 November 2006; 
revised 31 May 2007; 
accepted 12 June 2007. 
Available online 14 June 2007.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

A series of anacardic acid analogues possessing different side chains viz. phenolic, branched, and alicyclic were synthesized and their antibacterial activity tested against methicillin-resistant Staphylococcus aureus (MRSA). The maximum activity against this bacterium occurred with the branched side-chain analogue, 6-(4′,8′-dimethylnonyl)salicylic acid, and the alicyclic side-chain analogue, 6-cyclododecylmethyl salicylic acid, with the minimum inhibitory concentration (MIC) of 0.39 μg/mL, respectively. This activity was superior to that of the most potent antibacterial anacardic acid isolated from the cashew Anacardium occidentale (Anacardiaceae), apple and nut, that is, the 6-[8′(Z),11′(Z),14′-pentadecatrienyl]salicylic acid.

Graphical abstract


Keywords: Methicillin-resistant Staphylococcus aureus (MRSA); Antibacterial; Anacardic acid analogue; 6-(4′,8′-Dimethylnonyl)salicylic acid

Article Outline

1. Introduction
2. Results and discussion
3. Conclusion
4. Experimental
4.1. Chemicals
4.2. Synthesis
4.3. Test organism and medium
4.4. MIC determination
4.5. Log P calculation
Acknowledgements
References




Bioorganic & Medicinal Chemistry
Volume 15, Issue 18, 15 September 2007, Pages 6236-6241
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.